Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma.
about
Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery.Discovery of novel serum biomarkers for prenatal Down syndrome screening by integrative data mining.Quantitative plasma proteomic profiling identifies the vitamin E binding protein afamin as a potential pathogenic factor in SIV induced CNS disease.The Use of Proteomics in Assisted Reproduction.Gene expression profiling in a mouse model identifies fetal liver- and placenta-derived potential biomarkers for Down Syndrome screening.Placenta proteome analysis from Down syndrome pregnancies for biomarker discovery.Quantitative proteomic analysis of serum from pregnant women carrying a fetus with conotruncal heart defect using isobaric tags for relative and absolute quantitation (iTRAQ) labelingMaternal serum protein profile and immune response protein subunits as markers for non-invasive prenatal diagnosis of trisomy 21, 18, and 13.Determination of fetal chromosome aberrations from fetal DNA in maternal blood: has the challenge finally been met?2D DIGE analysis of maternal plasma for potential biomarkers of Down SyndromeTwo-Dimensional Differential Gel Electrophoresis to Identify Protein Biomarkers in Amniotic Fluid of Edwards Syndrome (Trisomy 18) Pregnancies.Bioinformatics characterization of differential proteins in serum of mothers carrying Down syndrome fetuses: combining bioinformatics and ELISA.Biomarker development for non-invasive prenatal diagnosis of fetal aneuploidies: predictive reliability and potential clinical application.Maternal serum proteome changes between the first and third trimester of pregnancy in rural southern Nepal.Brief Communication: Maternal Plasma Autoantibodies Screening in Fetal Down Syndrome.Non invasive prenatal diagnosis of aneuploidy: next generation sequencing or fetal DNA enrichment?Proteomic technologies for prenatal diagnostics: advances and challenges ahead.Plasma protein profiling of Mild Cognitive Impairment and Alzheimer's disease using iTRAQ quantitative proteomics.Unraveling the complexity of neurodegeneration in brains of subjects with Down syndrome: insights from proteomics.Down syndrome screening: imagining the screening test of the future.Application of proteomics to prenatal screening and diagnosis for aneuploidies.Proteomic analysis of amniotic fluid for the diagnosis of fetal aneuploidies.Bioinformatics approaches in the discovery and understanding of reproduction-related biomarkers.Clinical proteomics in obstetrics and neonatology.Identification of novel candidate maternal serum protein markers for Down syndrome by integrated proteomic and bioinformatic analysis.Proteomic profile of serum of pregnant women carring a fetus with Down syndrome using nano uplc Q-tof ms/ms technology.Disturbance of redox homeostasis in Down Syndrome: Role of iron dysmetabolism.Quantitative performance of antibody array technology in a prenatal screening setting.Serum amyloid-p (SAP), a potential biomarker for Down syndrome fetuses prevention in maternal plasma.Maternal serum CA 19-9 and CA 15-3 levels in pregnancies affected by trisomy 21.Plasma biomarkers for the identification of women at risk for early-onset preeclampsia.
P2860
Q30524877-79FA3F30-AE0D-449D-995B-5B7AAC371372Q30943859-682BB87A-18C5-459A-9338-9CAF77A4BEA8Q33571865-DE819D78-0605-40EE-8E12-E336375067DCQ33770728-E1F12207-CD46-46D4-B669-810B76D02895Q33886427-380AC1D4-458A-409E-AF13-1925A6939140Q34331621-FCD359F0-414C-4124-862E-585020E85F06Q34505748-E10732F5-956D-45FB-A09D-C488396DA438Q34570581-638B9C6F-8961-42BC-A9D5-ECD7013E819EQ34921561-672C8749-461C-4A65-8CFF-7750255C41C4Q35298620-A1460C3C-75BB-41CD-B8D0-4E7C5DA1A4FFQ35890658-123C44A6-6558-4049-B618-787D15C67215Q35990381-8C2D12A7-23E9-44BF-9371-128FC74FE89BQ36117903-68FE2679-2933-4709-A70C-96F1342D168EQ36435662-B82260C3-6CA7-4834-A1EE-5FCAD34A5297Q36706466-BAA91539-6849-4CD4-BC4C-1AAAF7B9D842Q37181536-ECC37952-0F59-454D-A5C0-BB3570BECE6DQ37390676-E3F9766A-DF41-4E10-9999-CF1E916D1D38Q37504001-AC9DA4BE-0211-4835-851D-920A47E4FA51Q37662773-311E1CDA-8189-48D9-A661-F1F3114A7982Q37750847-7BABDAFB-A37E-4904-B6E5-21EE7996DA5AQ37801660-F0806736-A38F-43F3-86E3-C1F04D9E9A91Q37866306-C9AB9104-9DBB-411F-8F2A-57B4BCD60E8AQ37866308-73F11F93-7CC9-479B-8D81-9C95E3EEE7A1Q38176934-9ACC69AA-4B4A-40E6-809F-8BC5972FF34FQ38497910-585CC089-9457-4D94-B39E-2D0F2CFDD671Q38835303-F22CEA13-0925-4E0C-8D58-3B5B32C28D85Q39433562-34A1AE07-DC2A-4785-A8A6-79ACCABBC950Q39692651-9D76E980-96E8-4454-A8B1-DE3CC300547CQ46041480-CA0A1C55-AD53-4719-9BFA-BEBE0B35F903Q49122019-AD75F8E7-EC94-4B38-86CF-E3363D826516Q51129015-9358AEC5-860A-44D0-BA53-E9CB266D283B
P2860
Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Application of proteomics for ...... n syndrome in maternal plasma.
@ast
Application of proteomics for ...... n syndrome in maternal plasma.
@en
type
label
Application of proteomics for ...... n syndrome in maternal plasma.
@ast
Application of proteomics for ...... n syndrome in maternal plasma.
@en
prefLabel
Application of proteomics for ...... n syndrome in maternal plasma.
@ast
Application of proteomics for ...... n syndrome in maternal plasma.
@en
P2093
P356
P1433
P1476
Application of proteomics for ...... n syndrome in maternal plasma.
@en
P2093
Aggeliki Kolialexi
Ariadni Mavrou
Aris Antsaklis
Athanasios K Anagnostopoulos
George Th Tsangaris
Kostantinos Vougas
Nikos Papantoniou
Vassilis Bagiokos
P2860
P304
P356
10.1002/PD.2040
P577
2008-08-01T00:00:00Z